Prevnar 13 vaccine endorsed for elderly by U.S. panel

08/14/2014 | Reuters

The Advisory Committee on Immunization Practices voted 13 to 2 to endorse the use of Pfizer's Prevnar 13 vaccine to protect people 65 and older from pneumococcal bacteria that can lead to infections such as pneumonia. However, the panel is worried that Medicare will not cover the vaccine for patients who were already treated with Merck's Pneumovax vaccine. Medicare would have to adjust its policies in order for such patients to be eligible for reimbursement, an official for the insurance program said.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC